Back to PHM.MCView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Axial and Peripheral Spondyloarthritis
View Full LandscapeDrug Information
Target Indication
Axial and Peripheral Spondyloarthritis
Clinical Trial
NCT01590966Last updated: 9/9/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
subcutaneous apomorphinePhase 3
Motor OFF Episodes Associated With Parkinson's Disease
Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUATPhase 3
Allergic Rhinitis
Oxycodone HCl controlled-release tabletsPhase 3
Pain
nateglinidePhase 3
Type 2 Diabetes Mellitus
approved egg-derived TIVPhase 3
Influenza
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts